KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Cash from Operations (2016 - 2025)

Edwards Lifesciences (EW) has 17 years of Cash from Operations data on record, last reported at 450900000.0 in Q4 2025.

  • For Q4 2025, Cash from Operations rose 453.65% year-over-year to 450900000.0; the TTM value through Dec 2025 reached 1595200000.0, up 194.15%, while the annual FY2025 figure was 1595200000.0, 194.15% up from the prior year.
  • Cash from Operations reached 450900000.0 in Q4 2025 per EW's latest filing, down from 573700000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 573700000.0 in Q3 2025 and bottomed at 127500000.0 in Q4 2024.
  • Average Cash from Operations over 5 years is 299180000.0, with a median of 312000000.0 recorded in 2022.
  • The widest YoY moves for Cash from Operations: up 1005.65% in 2024, down 193.34% in 2024.
  • A 5-year view of Cash from Operations shows it stood at 373600000.0 in 2021, then fell by 24.3% to 282800000.0 in 2022, then crashed by 51.7% to 136600000.0 in 2023, then plummeted by 193.34% to 127500000.0 in 2024, then skyrocketed by 453.65% to 450900000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Operations were 450900000.0 in Q4 2025, 573700000.0 in Q3 2025, and 290200000.0 in Q2 2025.